Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC E0924G | 2909474-29-7 | 99.2% | 232.24 | 1 ML
SDP

Catalog No. 5000390445
Encompass_Preferred

E0924G is an orally active activator for PPARδ with an EC50 of 2.82 μM. It promotes the upregulation of osteoprotegerin (OPG) with an EC50 of 0.29 μM. E0924G reduces RANKL-induced osteoclast differentiation and inhibits F-actin ring formation in RAW264.7 macrophages. It also regulates bone density and bone loss in ovariectomized (OVX) and age-related osteoporosis models.

  • Orally active activator for PPARδ
  • Promotes upregulation of osteoprotegerin (OPG)
  • Reduces RANKL-induced osteoclast differentiation
  • Inhibits F-actin ring formation in RAW264.7 macrophages
  • Regulates bone density and bone loss

Catalog No. 50-003-90445 Supplier Medchemexpress LLC Supplier No. HY16833610MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

E0924G is an orally active activator for PPARδ with an EC50 of 2.82 μM. It promotes the upregulation of osteoprotegerin (OPG) with an EC50 of 0.29 μM. E0924G reduces RANKL-induced osteoclast differentiation and inhibits F-actin ring formation in RAW264.7 macrophages. It also regulates bone density and bone loss in ovariectomized (OVX) and age-related osteoporosis models.

  • Orally active activator for PPARδ
  • Promotes upregulation of osteoprotegerin (OPG)
  • Reduces RANKL-induced osteoclast differentiation
  • Inhibits F-actin ring formation in RAW264.7 macrophages
  • Regulates bone density and bone loss

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.